Psychological distress in inflammatory bowel disease

References

• GBD 2017 Inflammatory Bowel Disease Collaborators. Global Burden of Disease Study. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30.
   PubMed Web of Science ®Google Scholar
• Zhao M, Gönczi L, Peter L, et al. The burden of inflammatory bowel disease in Europe in 2020. J Crohn’s Colitis. 2021;15(9):1573–1587.
   Google Scholar
• Dubinsky MC, Dotan I, Rubin DT, et al. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert Rev Gastroenterol Hepatol. 2021 Sep;15(9):985–997.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Williams CJM, Sood R, et al. Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease. Am J Gastroenterol. 2016;111(4):541–551. DOI:10.1038/ajg.2016.59
   PubMed Web of Science ®Google Scholar
• Leone D, Gilari D, Corrò BE, et al. Psychological characteristics of inflammatory bowel disease patients: a comparison between active and nonactive patients. Inflamm Bowel Dis. 2019 Jul 17;25(8):1399–1407.
   PubMed Web of Science ®Google Scholar
• Barberio B, Zamani M, Black CJ, et al. Prevalence of symptoms of anxiety and depression in patients with inflamma- tory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359–370.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Wilson JL, Connell WR, et al. Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn's disease guided by the common sense model of illness. Inflamm Bowel Dis. 2011;17(12):2551–2557. DOI:10.1002/ibd.21650
   PubMed Web of Science ®Google Scholar
• Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570–1583. DOI:10.1053/j.gastro.2020.12.031
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324–1338. DOI:10.1038/ajg.2015.233
   PubMed Web of Science ®Google Scholar
• Park KT, Ehrlich OG, Allen JI, et al. The cost of inflammatory bowel disease: an initiative from the Crohn’s & Colitis foundation. Inflamm Bowel Dis. 2020;26(1):1–10. DOI:10.1093/ibd/izz104
   PubMed Web of Science ®Google Scholar
• Parian AM, Chen P-H, Lazarev M, et al. Comorbid psychiatric diagnoses are common among IBD hospitalizations and increase healthcare utilization: a nationwide analysis. Gastroenterology. 2016;150(4):S1002. DOI:10.1016/S0016-5085(16)33394-7
   Web of Science ®Google Scholar
• Kochar B, Barnes EL, Long MD, et al. Depression is associated with more aggressive inflammatory bowel disease. J Gastroenterol. 2018 Jan;113(1):80–85.
   Web of Science ®Google Scholar
• Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(5):1470Y1479. DOI:10.1111/j.1572-0241.2001.03800.x
   Web of Science ®Google Scholar
• Maunder RG. Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis and future directions. Inflamm Bowel Dis. 2005;11(6):600Y608.
   Web of Science ®Google Scholar
• Thomson EF, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis. 2006 Aug;12(8):697–707.
   PubMed Web of Science ®Google Scholar
• Peppas S, Pansieri C, Piovani D, et al. The brain-gut axis: psychological functioning and inflammatory bowel diseases. Clin Med. 2021;10(3):377. DOI:10.3390/jcm10030377
   Web of Science ®Google Scholar
• Sun Y, Li L, Xie R, et al. Stress triggers flare of inflammatory bowel disease in children and adults. Front Pediatr. 2019;24(7):432.
   Google Scholar
• Brzozowski B, Mazur-Bialy A, Pajdo R, et al. Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease (IBD): role of brain-gut axis. Curr Neuropharmacol. 2016;14(8):892–900. DOI:10.2174/1570159X14666160404124127
   PubMed Web of Science ®Google Scholar
• Koloski NA, Jones M, Kalantar J, et al. The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284–1290.
   PubMed Web of Science ®Google Scholar
• Jones MP, Dilley JB, Drossman D, et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006;18(2):91–103.
   PubMed Web of Science ®Google Scholar
• Keller M, Mazuch J, Abraham U, et al. A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci. 2009;106(50):21407–21412. DOI:10.1073/pnas.0906361106
   PubMed Web of Science ®Google Scholar
• Arjona A, Sarkar DK. Are circadian rhythms the code of hypothalamic–immune communication? Insights from natural killer cells. Neurochem Res. 2008;33(4):708–718.
   PubMed Web of Science ®Google Scholar
• Johnson JD, Campisi J, Sharkey CM, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 2005;135(4):1295–1307.
   PubMed Web of Science ®Google Scholar
• Farhadi A, Keshavarzian A, Van de Kar LD, et al. Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol. 2005;100(8):1796–1804. DOI:10.1111/j.1572-0241.2005.50071.x
   PubMed Web of Science ®Google Scholar
• Mittal R, Debs LH, Patel AP. Neurotransmitters: the critical modulators regulating gut-brain axis. Cell Physiol. 2017 Sep;232(9):2359–2372.
   Google Scholar
• Hill LT, Kidson SH, Michell WL. Corticotropin-releasing factor: a possible key to gut dysfunction in the critically ill. Nutrition. 2013;29(7–8):948–952.
   PubMed Web of Science ®Google Scholar
• Santos J, Saunders PR, Hanssen NP, et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol. 1999;277(2):G391–9. DOI:10.1152/ajpgi.1999.277.2.G391
   PubMedGoogle Scholar
• Goyal RK, Hirano I, Epstein FH. The enteric nervous system. N Engl J Med. 1996;334(17):1106–1115.
   PubMed Web of Science ®Google Scholar
• Duan H, Cai X, Luan Y. Regulation of the autonomic nervous system on intestine. Front Physiol. 2021 Jul;14(12):700129.
   Google Scholar
• Zeng M, Inohara N, Nuñez G. Mechanisms of inflammation driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10(1):18.
   PubMed Web of Science ®Google Scholar
• Madison A, Kiecolt-Glaser JK. Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Opin Behav Sci. 2019;28:105–110.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4(8):632–642.
   PubMed Web of Science ®Google Scholar
• Lazarus R, Folkman S. Stress, appraisal and coping. (NY) (NY): Springer Publishing Company; 1984.
   Google Scholar
• Folkman S, Lazarus RS, Gruen RJ, et al. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol. 1986 Mar;50(3):571–579.
   PubMed Web of Science ®Google Scholar
• Bernstein CN. Psychological stress and depression: risk factors for IBD? Dig Dis. 2016;34(1–2):58–63.
   PubMed Web of Science ®Google Scholar
• Lerebours E, Gower-Rousseau C, Merle V, et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case–control study. Am J Gastroenterol. 2007;102(1):122–131. DOI:10.1111/j.1572-0241.2006.00931.x
   PubMed Web of Science ®Google Scholar
• Bisgaard TH, Allin KH, Keefer L, et al. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022 Nov;19(11):717–726.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312.
   PubMed Web of Science ®Google Scholar
• Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997;48(1):191–214.
   PubMed Web of Science ®Google Scholar
• Li J, Nørgard B, Precht DH, et al. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am J Gastroenterol. 2004;99(6):1129–1133. DOI:10.1111/j.1572-0241.2004.04155.x
   PubMed Web of Science ®Google Scholar
• Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study. a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103(8):1989–1997. DOI:10.1111/j.1572-0241.2008.01980.x
   PubMed Web of Science ®Google Scholar
• Sexton KA, Walker JR, Graff LA, et al. Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(3):473–483. DOI:10.1097/MIB.0000000000001040
   PubMed Web of Science ®Google Scholar
• Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008;118:2209–2218.
   PubMed Web of Science ®Google Scholar
• Varghese AK, Verdú EF, Bercik P, et al. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology. 2006;130:1743–1753.
   PubMed Web of Science ®Google Scholar
• Targownik LE, Sexton KA, Bernstein MT. The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease. Gastroenterol. 2015;110(7):1001–1012.
   Web of Science ®Google Scholar
• Mawdsley JE, Macey MG, Feakins RM, et al. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006;131(2):410–419. DOI:10.1053/j.gastro.2006.05.017
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105(9):1994–2002.
   PubMed Web of Science ®Google Scholar
• Black J, Sweeney L, Yuan Y, et al. Systematic review: the role of psychological stress in inflammatory bowel disease. Aliment Pharmacol Ther. 2022;56(8):1235–1249. DOI:10.1111/apt.17202
   PubMed Web of Science ®Google Scholar
• Sauk JS, Ryu HJ, Labus JS, et al. High perceived stress is associated with increased risk of ulcerative colitis clinical flares. Clin Gastroenterol Hepatol. 2022;S1542-3565(22):00721–2.
   Google Scholar
• Mardini HE, Kip KE, Wilson JW. Crohn’s disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 2004;49(3):492–497.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Hofstetter A, Wolfe F, et al. Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study. Inflamm Bowel Dis. 2013;19(11):2380–2386. DOI:10.1097/MIB.0b013e3182a192ba
   PubMed Web of Science ®Google Scholar
• Schoultz M, Beattie M, Trish Gorely T, et al. Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a systematic review utilising Bradford Hill criteria and meta-analysis of prospective cohort studies. Syst Rev. 2020;9(1):169. DOI:10.1186/s13643-020-01426-2
   PubMed Web of Science ®Google Scholar
• Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000;95(5):1213–1220. DOI:10.1111/j.1572-0241.2000.02012.x
   PubMed Web of Science ®Google Scholar
• Bitton A, Dobkin PL, Edwardes MD, et al. Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut. 2008;57(10):1386–1392. DOI:10.1136/gut.2007.134817
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus A, Knowles SR, Keefer L, et al. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(3):752–762. DOI:10.1097/MIB.0000000000000620
   PubMed Web of Science ®Google Scholar
• Neuendorf R, Harding A, Stello N, et al. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34(1):119–138.
   PubMed Web of Science ®Google Scholar
• Malhi GS, John Mann J J. Depression. Lancet. 2018;392(10161):2299–2312.
   PubMed Web of Science ®Google Scholar
• Panara AJ, Yarur AJ, Rieders B, et al. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther. 2014;39(8):802–810. DOI:10.1111/apt.12669
   PubMed Web of Science ®Google Scholar
• Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97(2):389–396. DOI:10.1016/S0002-9270(01)04037-0
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Hamlin JP, Ford AC. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. Am J Gastroenterol. 2018;113(5):702–712.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Olén O, Larsson H, et al. Association between inflammatory bowel disease and psychiatric morbidity and suicide: a Swedish nationwide population-based cohort study with sibling comparisons. J Crohns Colitis. 2021;15(11):1824–1836. DOI:10.1093/ecco-jcc/jjab039
   PubMed Web of Science ®Google Scholar
• Thavamani A, Umapathi KK, Khatana J, et al. Burden of psychiatric disorders among pediatric and young adults with inflammatory bowel disease: a population-based analysis. Pediatr Gastroenterol Hepatol Nutr. 2019;22(6):527–535.
   PubMed Web of Science ®Google Scholar
• Brooks AJ, Rowse G, Ryder A, et al. Systematic review: psychological morbidity in young people with inflammatory bowel disease - risk factors and impacts. Aliment Pharmacol Ther. 2016;44(1):3–15.
   PubMed Web of Science ®Google Scholar
• Gamwell KL, Baudino MN, Bakula DM, et al. Perceived illness stigma, thwarted belongingness, and depressive symptoms in youth with inflammatory bowel disease (IBD). Inflamm Bowel Dis. 2018;24(5):960–965. DOI:10.1093/ibd/izy011
   PubMed Web of Science ®Google Scholar
• Roberts CM, Gamwell KL, Baudino MN, et al. The contributions of illness stigma, health communication difficulties, and thwarted belongingness to depressive symptoms in youth with inflammatory bowel disease. J Pediatr Psychol. 2020;45:81–90.dos.
   PubMed Web of Science ®Google Scholar
• Taft TH, Keefer L, Leonhard C, et al. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 2009;15(8):1224–1232.
   PubMed Web of Science ®Google Scholar
• Taft TH, Keefer L. A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease. Clin Exp Gastroenterol. 2016;9:49–58.
   PubMed Web of Science ®Google Scholar
• Roberts CM, Caroline M, Baudino MN, et al. Illness stigma, worry, intrusiveness, and depressive symptoms in youth with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2021;72(3):404–409. DOI:10.1097/MPG.0000000000002939
   PubMed Web of Science ®Google Scholar
• Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35(8):857–869. DOI:10.1093/jpepsy/jsp120
   PubMed Web of Science ®Google Scholar
• Roberts CM, Caroline M, Baudino MN, et al. Illness stigma, body image dissatisfaction, thwarted belongingness and depressive symptoms in youth with inflammatory bowel disease. J Gastroenterol Hepatol. 2022;34(9):919–924. DOI:10.1097/MEG.0000000000002420
   Google Scholar
• Gaines LS, Slaughter JC, Horst SN, et al. Association Between Affective-Cognitive Symptoms of Depression and Exacerbation of Crohn’s Disease. Am J Gastroenterol. 2016;111(6):864–870.
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus A, Pittet V, Rossel JB, et al. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2016;14(6):829–835. DOI:10.1016/j.cgh.2015.12.045
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Guthrie EA, Hamlin PJ, et al. Bi-directionality of brain–Gut interactions in patients with inflammatory bowel disease. Gastroenterology. 2018;154(6):1635–1646. DOI:10.1053/j.gastro.2018.01.027
   PubMedGoogle Scholar
• Long MD, Kappelman MD, Martin CF, et al. Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis. 2014;8(2):113–119. DOI:10.1016/j.crohns.2013.07.002
   PubMed Web of Science ®Google Scholar
• Dubinsky MC, Dotan I, Rubin DT, et al. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert Review of Gastroenterol Hepatol. 2021;15(9):985–997. DOI:10.1080/17474124.2021.1911644
   PubMed Web of Science ®Google Scholar
• Moradkhani A, Beckman LJ, Tabibian JH. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors. Crohn’s Colitis. 2013 Jul;7(6):467–473.
   PubMed Web of Science ®Google Scholar
• Iglesias-Rey M, Barreiro-de Acosta M, Caamano-Isorna F, et al. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(1):92–102. DOI:10.1097/01.MIB.0000436955.78220.bc
   PubMed Web of Science ®Google Scholar
• Luo XP, Mao R, Chen BL, et al. Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease. Patient Prefer Adherence. 2016;11:23–31.
   PubMed Web of Science ®Google Scholar
• Buist-Bouwman MA, de Graaf R, Vollebergh WA, et al. Comorbidity of physical and mental disorders and the effect on work-loss days. Acta Psychiatr Scand. 2005;111(6):436–443.
   PubMed Web of Science ®Google Scholar
• Bertomoro P, Vettorato MG, Simonetti F, et al. Inflammatory bowel disease and psychological status: determinants and social consequences. Dig Liver Dis. 2015;47(2):e138–139.
   PubMedGoogle Scholar
• Chan W, Shim HH, Lim MS, et al. Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Dig Liver Dis. 2017;49(12):1314–1319. DOI:10.1016/j.dld.2017.08.020
   PubMedGoogle Scholar
• Lewis K, Marrie RA, Bernstein CN, et al. The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(10):1674–1680. DOI:10.1093/ibd/izz045
   PubMed Web of Science ®Google Scholar
• Marrie RA, Walker JR, Graff LA, et al. “Defining the burden and managing the effects of psychiatric comorbidity in chronic immune inflammatory disease” Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. J Psychosom Res. 2016;89:107–113.
   PubMed Web of Science ®Google Scholar
• Hu S, Chen Y, Chen Y, et al. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatry. 2021;12:714057.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Mühlig S, Beesdo K. Mental disorders in primary care. Dialogues Clin Neurosci. 2003;5(2):115–128.
   PubMedGoogle Scholar
• Bernstein CN, Zhang L, Lix LM, et al. CIHR team in defining the burden and managing the effects of immune-mediated inflammatory disease. The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(9):1867–1875. DOI:10.1093/ibd/izy068
   PubMed Web of Science ®Google Scholar
• Avinir A, Dar S, Taler M. Keeping it simple: mental health assessment in the gastroenterology department- using the hospital anxiety and depression scale (HADS) for IBD patients in Israel. Therap Adv Gastroenterol. 2022;15:17562848211066439.
   Web of Science ®Google Scholar
• Persoons P, Vermeire S, Demyttenaere K. The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment Pharmacol Ther. 2005;22(2):101–110.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Persoons P, Luyckx K, Fischler B. Psychiatric diagnoses in gastroenterology: validation of a self-report instrument (PRIME-MD PHQ), epidemiology and recognition. Gastroenterology. 2001;120(5):615.
   Web of Science ®Google Scholar
• Hu S, Chen Y, Wang C. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatry. 2021;12:714057.
   PubMed Web of Science ®Google Scholar
• Wang YP, Gorenstein C. Assessment of depression in medical patients: a systematic review of the utility of the beck depression inventory-II. Clinics. 2013;68(9):1274–1287.
   PubMed Web of Science ®Google Scholar
• Mulvaney Day N, Marshall T, Downey Piscopo K, et al. Screening for behavioral health conditions in primary care settings: a systematic review of the literature. J Gen Intern Med. 2018;33(3):335–346. DOI:10.1007/s11606-017-4181-0
   PubMed Web of Science ®Google Scholar
• Hanlon C, Medhin G, Selamu M, et al. Validity of brief screening questionnaires to detect depression in primary care in Ethiopia. J Affect Disord. 2015 Nov 1;186:32–39.
   PubMed Web of Science ®Google Scholar
• Costantini L, Pasquarella C, Odone A, et al. Screening for depression in primary care with patient health questionnaire-9 (PHQ-9): a systematic review. J Affect Disord. 2021 Jan 15;279:473–483.
   PubMed Web of Science ®Google Scholar
• Strober LB, Arnett PA. Depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure. J Clin Exp Neuropsychol. 2015;37(7):722–732.
   PubMed Web of Science ®Google Scholar
• Löwe B, Spitzer RL, Gräfe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78(2):131–140. DOI:10.1016/S0165-0327(02)00237-9
   PubMed Web of Science ®Google Scholar
• Purvis TE, Neuman BJ, Riley LH, et al. Comparison of PROMIS anxiety and depression, PHQ-8, and GAD-7 to screen for anxiety and depression among patients presenting for spine surgery. J Neurosurg Spine. 2019;18(4):1–8.
   Google Scholar
• Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325.
   PubMed Web of Science ®Google Scholar
• Miller P, Newby D, Walkom E, et al. The performance and accuracy of depression screening tools capable of self-administration in primary care: a systematic review and meta-analysis. Eur J Psych. 2021;35(1):1–18.
   Web of Science ®Google Scholar
• De Graaff AM, Cuijpers P, Leeflang M, et al. A systematic review and meta-analysis of diagnostic test accuracy studies of self-report screening instruments for common mental disorders in Arabic-speaking adults. Glob Ment Health. 2021;23(8):e43.
   Google Scholar
• Mikocka-Walus A, Knowles SR, Keefer L, et al. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(3):752–762.
   PubMed Web of Science ®Google Scholar
• Bryant RA. Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges. World Psychiatry. 2019;18(3):259–269.
   PubMed Web of Science ®Google Scholar
• Soldatos CR, Paparrigopoulos TJ, Pappa DA, et al. Early post-traumatic stress disorder in relation to acute stress reaction: an ICD-10 study among help seekers following an earthquake. Psychiatry Res. 2006;143(2–3):245–253. DOI:10.1016/j.psychres.2005.05.018
   PubMed Web of Science ®Google Scholar
• O’Connor M, Christensen S, Jensen AB, et al. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer. 2011;104(3):419–426. DOI:10.1038/sj.bjc.6606073
   PubMed Web of Science ®Google Scholar
• Cámara RJ, Gander ML, Begré S, et al. Swiss Inflammatory Bowel Disease Cohort Study Group Post-traumatic stress in Crohn’s disease and its association with disease activity. Frontline Gastroenterol. 2011;2(1):2–9.
   PubMedGoogle Scholar
• Taft TH, Bedell A, Craven MR, et al. Initial assessment of post-traumatic stress in a US cohort of inflammatory bowel disease patients. Inflamm Bowel Dis. 2019;25(9):1577–1585. DOI:10.1093/ibd/izz032
   PubMed Web of Science ®Google Scholar
• Pietrzak RH, Goldstein RB, Southwick SM, et al. Prevalence and axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from wave 2 of the National Epidemiologic Survey on alcohol and related conditions. J Anxiety Disord. 2011;25(3):456–465. DOI:10.1016/j.janxdis.2010.11.010
   PubMed Web of Science ®Google Scholar
• Tolin DF, Foa EB. Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psychol Bull. 2006;132(6):959–992.
   PubMed Web of Science ®Google Scholar
• Taft TH, McGarva J, Omprakash TA, et al. Hospitalization experiences and post-traumatic stress in inflammatory bowel disease: opportunities for change. Inflamm Bowel Dis. 2022 Jul 27: izac148. DOI:10.1093/ibd/izac148
   Web of Science ®Google Scholar
• Taft TH, Quinton S, Jedel S, et al. Post-traumatic stress in patients with inflammatory bowel disease: prevalence and relationships to patient-reported outcomes. Inflamm Bowel Dis. 2022 May 4;28(5):710–719.
   PubMed Web of Science ®Google Scholar
• Pothemont K, Quinton S, Jayoushe M, et al. Patient perspectives on medical trauma related to inflammatory bowel disease. Psychol Med Settings. 2022 Sep;29(3):596–607.
   PubMed Web of Science ®Google Scholar
• Langford DJ, Theodore BR, Balsiger D, et al. Number and type of post-traumatic stress disorder symptom domains are associated with patient-reported outcomes in patients with chronic pain. J Pain. 2018;19(5):506–514.
   PubMed Web of Science ®Google Scholar
• Weathers FW, Blake DD, Schnurr PP, et al. The clinician-administered PTSD scale for DSM–5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383–395. 2013. DOI:10.1037/pas0000486
   PubMed Web of Science ®Google Scholar
• Prins A, Bovin MJ, Smolenski DJ, et al. The primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a Veteran primary care sample. J Gen Intern Med. 2016;31(10):1206–1211. DOI:10.1007/s11606-016-3703-5
   PubMed Web of Science ®Google Scholar
• Blevins CA, Weathers FW, Davis MT, et al. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–498. 2015. DOI:10.1002/jts.22059
   PubMed Web of Science ®Google Scholar
• Holland G, Tiggemann M. A systematic review of the impact of the use of social networking sites on body image and disordered eating outcomes. Body Image. 2016;17:100–110.
   PubMed Web of Science ®Google Scholar
• McDermott E, Mullen G, Moloney J, et al. Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(2):353–360.
   PubMed Web of Science ®Google Scholar
• Clayot JD, Kochar B, Kappelman MD, et al. Body image dissatisfaction among pediatric patients with inflammatory bowel disease. J Paediatr. 2020;223:68–72.
   PubMed Web of Science ®Google Scholar
• Saha S, Zhao YQ, Shah SA, et al. Body image dissatisfaction in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(2):345–352. DOI:10.1097/MIB.0000000000000270
   PubMed Web of Science ®Google Scholar
• Beese SE, Harris IM, Dretzke J, et al. Body image dissatisfaction in patients with inflammatory bowel disease: a systematic review. BMJ Open Gastroenterol. 2019;6(1):e000255.
   PubMed Web of Science ®Google Scholar
• Jedel S, Hood MM, Keshavarzian A. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015 Apr;21(4):923–938.
   PubMed Web of Science ®Google Scholar
• Pires F 1, Martins D, Ministro P. A survey on the impact of IBD in sexual health: into intimacy. Medicine. 2022;101(52):e32279. 1. DOI:10.1097/MD.0000000000032279
   PubMed Web of Science ®Google Scholar
• Trindade IA, Ferreira C, Pinto-Gouveia J. The effects of body image impairment on the quality of life of non-operated Portuguese female IBD patients. Qual Life Res. 2017;26(2):429–436.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Gass C, Macrae F. Illness perceptions in IBD influence psychological status, sexual health and satisfaction, body image and relational functioning: a preliminary exploration using structural equation modeling. J Crohns Colitis. 2013;7(9):e344–350.
   PubMed Web of Science ®Google Scholar
• Rivière P, Zallot C, Desobry P, et al. Frequency of and factors associated with sexual dysfunction in patients with inflammatory bowel disease. J Crohns Colitis. 2017;11(11):1347–1352. DOI:10.1093/ecco-jcc/jjx100
   PubMed Web of Science ®Google Scholar
• Allison M, Lindsay J, Gould D, et al. Surgery in young adults with inflammatory bowel disease: a narrative account. Int J Nurs Stud. 2013;50(11):1566–1575. DOI:10.1016/j.ijnurstu.2013.04.003
   PubMed Web of Science ®Google Scholar
• Carlsson E, Bosaeus I, Nordgren S. What concerns subjects with inflammatory bowel disease and an ileostomy? Scand J Gastroenterol. 2003;38(9):978–984.
   PubMed Web of Science ®Google Scholar
• Muller KR, Prosser R, Bampton P, et al. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis. 2010;16(4):657–663. DOI:10.1002/ibd.21090
   PubMed Web of Science ®Google Scholar
• da Silva GM, Hull T, Roberts PL, et al. The effect of colorectal surgery in female sexual function, body image, self-esteem and general health: a prospective study. Ann Surg. 2008;248(2):266–272. DOI:10.1097/SLA.0b013e3181820cf4
   PubMed Web of Science ®Google Scholar
• Slors FJ, van Zuijlen PP, van Dijk GJ. Sexual and bladder dysfunction after total mesorectal excision for benign diseases. Scand J Gastroenterol Suppl. 2000;232:48–51.
   Google Scholar
• Ogilvie JW Jr, Goetz L, Baxter NN, et al. Female sexual dysfunction after ileal pouch–anal anastomosis. Br J Surg. 2008;95(7):887–892. DOI:10.1002/bjs.6072
   PubMed Web of Science ®Google Scholar
• Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch–anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol. 1999;34(2):185–188.
   PubMed Web of Science ®Google Scholar
• Hueting WE, Gooszen HG, van Laarhoven CJ. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a meta-analysis and a questionnaire survey. Int J Colorectal Dis. 2004;19(3):215–218.
   PubMed Web of Science ®Google Scholar
• Treasure J, Duarte TA, Schmidt U. Eating disorders. Lancet. 2020;395(10227):899–911.
   PubMed Web of Science ®Google Scholar
• Rangel Paniz RG, Lebow J, Sim L, et al. Eating disorders: diagnosis and management considerations for the IBD practice. Inflamm Bowel Dis. 2022 June 3;28(6):936–946.
   PubMed Web of Science ®Google Scholar
• Quick VM, Byrd-Bredbenner C, Neumark-Sztainer D. Chronic illness and disordered eating: a discussion of the literature. Adv Nutr. 2013;4(3):277–286.
   PubMed Web of Science ®Google Scholar
• Stoleru G, Leopold A, Auerbach A, et al. Female gender, dissatisfaction with weight, and number of IBD related surgeries as independent risk factors for eating disorders among patients with inflammatory bowel diseases. BMC Gastroenterol. 2022;22(1):438.
   PubMed Web of Science ®Google Scholar
• David JD, Chute D, Reed B, et al. Assessing the prevalence of and risk factors for disordered eating attitudes and behaviors in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2022;28(1):143–145. DOI:10.1093/ibd/izab154
   PubMed Web of Science ®Google Scholar
• Swanson SA, Crow SJ, Le Grange D, et al. Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement. Gen Psychiatry. 2011 Jul;68(7):714–723.
   PubMed Web of Science ®Google Scholar
• Kuźnicki P, Neubauer K. Emerging comorbidities in inflammatory bowel disease: eating disorders, alcohol and narcotics misuse. Clin Med. 2021;10(19):4623.
   Web of Science ®Google Scholar
• Murray HB, Jehangir A, Silvernale CJ, et al. Avoidant/Restrictive food intake disorder symptoms are frequent in patients presenting for symptoms of gastroparesis. Neurogastroenterol 1025 Motil. 2020;32(12):e13931. DOI:10.1111/nmo.13931
   PubMed Web of Science ®Google Scholar
• Fink M, Simons M, Tomasino K, et al. When is patient behavior indicative of avoidant restrictive food intake disorder (ARFID) Vs reasonable response to digestive disease? Gastroenterol Hepatol. 2022 Jun;20(6):1241–1250.
   Google Scholar
• Yelencich E, Truong E, Widaman AM. Avoidant restrictive food intake disorder prevalent among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1282–1289.
   PubMed Web of Science ®Google Scholar
• Zickgraf HF, Ellis JM. Initial validation of the nine item avoidant/restrictive food intake disorder screen (NIAS): a measure of three restrictive eating patterns. Appetite. 2018;123:32–42.
   PubMed Web of Science ®Google Scholar
• Gingold-Belfer R, Peled N, Levy S, et al. Impaired sleep quality in Crohn’s disease depends on disease activity. Dig Dis Sci. 2014;59(1):146–151. DOI:10.1007/s10620-013-2890-8
   PubMed Web of Science ®Google Scholar
• Ranjbaran Z, Keefer L, Farhadi A, et al. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22(11):1748–1753. DOI:10.1111/j.1440-1746.2006.04820.x
   PubMed Web of Science ®Google Scholar
• Keefer L, Stepanski EJ, Ranjbaran Z, et al. An initial report of sleep disturbance in inactive inflammatory bowel disease. J Clin Sleep Med. 2006;2(04):409–416. DOI:10.5664/jcsm.26656
   PubMedGoogle Scholar
• Burgess HJ, Swanson GR, Keshavarzian A. Endogenous melatonin profiles in asymptomatic inflammatory bowel disease. Scand J Gastroenterol. 2010;45(6):759–761.
   PubMed Web of Science ®Google Scholar
• Van Langenberg DR, Papandony MC, Gibson PR. Sleep and physical activity measured by accelerometry in Crohn’s disease. Aliment Pharmacol Ther. 2015;41(10):991–1004.
   PubMed Web of Science ®Google Scholar
• Ali T, Madhoun MF, Orr WC, et al. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflam Bowel Dis. 2013;19(11):2440–2443.
   PubMed Web of Science ®Google Scholar
• Iskandar HN, Linan EE, Patel A, et al. Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures. Sci Rep. 2020;10(1):1–9. DOI:10.1038/s41598-020-58807-9
   PubMed Web of Science ®Google Scholar
• Salwen-Deremer JK, Smith MT, Haskell HG, et al. Poor sleep in inflammatory bowel disease is reflective of distinct sleep disorders. Dig Dis Sci. 2022;67(7):3096–3107.
   PubMed Web of Science ®Google Scholar
• Graff LA, Vincent N, Walker JR, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(9):1882–1889. DOI:10.1002/ibd.21580
   PubMed Web of Science ®Google Scholar
• Sochal M, Małecka-Panas E, Gabryelska A, et al. Determinants of sleep quality in inflammatory bowel diseases. J Clin Med. 2020;9(9):2921. DOI:10.3390/jcm9092921
   PubMed Web of Science ®Google Scholar
• Sofia MA, Lipowska AM, Zmeter N, et al. Poor sleep quality in Crohn’s disease is associated with disease activity and risk for hospitalization or surgery. Inflam Bowel Dis. 2020;26:1251–1259.
   PubMed Web of Science ®Google Scholar
• Hyphantis TN, Tomenson B, Bai M, et al. Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig Dis Sci. 2010;55(3):724–732. DOI:10.1007/s10620-009-0762-z
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Long MD, Martin CF, et al. Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013;11(8):965–971.
   PubMed Web of Science ®Google Scholar
• Yuan S, Sun Y, Tan X, et al. Sleep duration and daytime napping in relation to incident inflammatory bowel disease: a prospective cohort study. Aliment Pharmacol Ther. 2022;57(5):475–485. DOI:10.1111/apt.17285
   PubMed Web of Science ®Google Scholar
• Junghaenel DU, Christodoulou C, Lai JS, et al. Demographic correlates of fatigue in the US general population: results from the patient-reported outcomes measurement information system (PROMIS) initiative. J Psychosom Res. 2011;71(3):117–123.
   PubMed Web of Science ®Google Scholar
• Shafer LA, Walker JR, Restall G, et al. Association between IBD disability and reduced work productivity (presenteeism): a population-based study in Manitoba, Canada. Inflamm Bowel Dis. 2019;25(2):352–359. DOI:10.1093/ibd/izy236
   PubMed Web of Science ®Google Scholar
• Zand A, van Deen WK, Inserra EK, et al. Presenteeism in in- flammatory bowel diseases: a hidden problem with significant economic impact. Inflamm Bowel Dis. 2015;21(7):1623–1630. DOI:10.1097/MIB.0000000000000399
   PubMed Web of Science ®Google Scholar
• Hindryckx P, Laukens D, D’Amico F, et al. Unmet needs in ibd: the case of fatigue. Clin Rev Allergy Immunol. 2018;55(3):368–378.
   PubMed Web of Science ®Google Scholar
• Nocerino A, Nguyen A, Agrawal M, et al. Fatigue in inflammatory bowel diseases: etiologies and management. Adv Ther. 2020;37(1):97–112.
   PubMed Web of Science ®Google Scholar
• Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci. 2001;933(1):185–200.
   PubMedGoogle Scholar
• Vogelaar L, de Haar C, Aerts BR, et al. Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parame- ters. Clin Exp Gastroenterol. 2017;10:83–90.
   PubMed Web of Science ®Google Scholar
• Jelsness-Jørgensen LP, Bernklev T, Henriksen M, et al. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011;17(7):1564–1572.
   PubMed Web of Science ®Google Scholar
• D’Silva A, Fox DE, Nasser Y, et al. Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis raman. Clin Gastroenterol Hepatol. 2022;20(5):995–1009.
   PubMed Web of Science ®Google Scholar
• van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32(2):131–143.
   PubMed Web of Science ®Google Scholar
• Minderhoud IM, Samsom M, Oldenburg B. Crohn’s disease, fatigue, and infliximab: is there a role for cytokines in the pathogenesis of fatigue? World J Gastroenterol. 2007;13(14):2089–2093.
   PubMed Web of Science ®Google Scholar
• Romberg-Camps MJ, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis. 2010;16(12):2137–2147. DOI:10.1002/ibd.21285
   PubMed Web of Science ®Google Scholar
• Tasson L, Zingone F, Barberio B, et al. Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases. Sci Rep. 2021;11(1):15251. DOI:10.1038/s41598-021-94685-5
   PubMed Web of Science ®Google Scholar
• Taft TH, Ballou S, Bedell A, et al. Psychological considerations and interventions in inflammatory bowel disease patient care. Gastroenterol Clin N an. 2017;46(4):847–858.
   PubMed Web of Science ®Google Scholar
• Graff LA, Clara I, Walker JR, et al. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors. Clin Gastroenterol Hepatol. 2013;11(9):1140–1146. DOI:10.1016/j.cgh.2013.03.031
   PubMed Web of Science ®Google Scholar
• Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen L-P, et al. Fatigue in a population- based cohort of patients with inflammatory bowel disease 20 years after diagnosis: the IBSEN study. Scand J Gastroenterol. 2017;52(3):351–358. DOI:10.1080/00365521.2016.1256425
   PubMed Web of Science ®Google Scholar
• Hashash JG, Ramos-Rivers C, Youk A. Quality of sleep and coexistent psychopathology have significant impact on fatigue burden in patients with inflammatory bowel disease. J Clin Gastroenterol. 2016;00:000–000.
   Google Scholar
• Czuber-Dochan W, Norton C, Bassett P, et al. Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale. J Crohns Colitis. 2014;8(11):1398–1406. DOI:10.1016/j.crohns.2014.04.013
   PubMed Web of Science ®Google Scholar
• Varbobitis I, Kokkotis G, Gizis M, et al. The IBD-F patient self-assessment scale accurately depicts the level of fatigue and predicts a negative effect on the quality of life of patients with ibd in clinical remission. Inflamm Bowel Dis. 2021;27(6):826–835. DOI:10.1093/ibd/izaa201
   PubMed Web of Science ®Google Scholar
• IBD UK. Crohn’s and colitis care in the UK: the hidden cost and a vision for change. IBD UK; published 2020. Accessed 2021.https://www.ibduk.org/reports/crohns-and-colitis-care-in-the-uk-the-hidden-cost-and-a-vision-for-change
   Google Scholar
• Hood M, Jedel S. Mindfulness-based interventions in inflammatory bowel disease. Gastroenterol Clin North Am. 2017 Dec;46(4):859–874.
   PubMed Web of Science ®Google Scholar
• Ewais T, Begun J, Kenny M, et al. A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease. Psychosom Res. 2019 Jan;116:44–53.
   PubMed Web of Science ®Google Scholar
• González-Moret R, Cebolla A, Cortés X, et al. The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial. Sci Rep. 2020;10(1):6071. DOI:10.1038/s41598-020-63168-4
   PubMed Web of Science ®Google Scholar
• Jedel S, Hoffman A, Merriman P, et al. A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative coli- tis. Digestion. 2014;89(2):142–155. DOI:10.1159/000356316
   PubMed Web of Science ®Google Scholar
• Gerbarg PL, Jacob VE, Laurie Stevens L, et al. The effect of breathing, movement, and meditation on psychological and physical symptoms and inflammatory biomarkers in inflammatory bowel disease: a randomized controlled trial. Inflamm Bowel Dis. 2015 Dec;21(12):2886–2896.
   PubMed Web of Science ®Google Scholar
• Sharma P, Poojary G, Velez DM, et al. Effect of yoga-based intervention in patients with inflammatory bowel disease. Int J Yoga Therap. 2015;25(1):101–112. DOI:10.17761/1531-2054-25.1.101
   PubMedGoogle Scholar
• Thompson RD, Delaney P, Flores I, et al. Cognitive-behavioral therapy for children with comorbid physical illness. Child Adolesc Psychiatr Clin N Am. 2011;20(2):329–348. DOI:10.1016/j.chc.2011.01.013
   PubMed Web of Science ®Google Scholar
• Szigethy E, Kenney E, Carpenter J, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1290–1298. DOI:10.1097/chi.0b013e3180f6341f
   PubMed Web of Science ®Google Scholar
• Thompson RD, Craig A, Crawford EA, et al. Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. J Clin Psychol Med Settings. 2012;19(3):329–337. DOI:10.1007/s10880-012-9301-8
   PubMed Web of Science ®Google Scholar
• Lee HH, Choi YY, Choi MG. The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2014;20(2):152.
   PubMed Web of Science ®Google Scholar
• Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings—Results from two randomized, controlled trials. Am J Gastroenterol. 2012;107(2):276–285. DOI:10.1038/ajg.2011.340
   PubMed Web of Science ®Google Scholar
• Peters SL, Muir G, Gibson PR. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther. 2015 Jun;41(11):1104–1115.
   PubMed Web of Science ®Google Scholar
• Hoekman DR, Vlieger AM, Pieter C, et al. Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial. Crohn's Colitis. 2021 Jul 5;15(7):1106–1113.
   PubMed Web of Science ®Google Scholar
• Keefer L, Taft TH, Kiebles JL, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis Aliment. Pharmacol Ther. Oct. 2013;38(7):761–771. DOI:10.1111/apt.12449
   Web of Science ®Google Scholar
• Mikocka-Walus AA, Gordon AL, Stewart BJ, et al. The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit. J Psychosom Res. 2012;72(2):165–167. DOI:10.1016/j.jpsychores.2011.06.006
   PubMed Web of Science ®Google Scholar
• Ford AC, Lacy BE, Harris LA, et al. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2019 Jan;114(1):21–39.
   PubMed Web of Science ®Google Scholar
• Blackwell J, Alexakis C, Saxena S, et al. Antidepressant medication use in inflammatory bowel disease: a nationally representative population-based study. en Gastroenterol. 2021 May;8(1):e000588.
   Google Scholar
• Jayasooriya N, Blackwell J, Saxena S, et al. Antidepressant medication use in inflammatory bowel disease: a nationally representative population-based study. Aliment Pharmacol Ther. 2022 May;55(10):1330–1341.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Gainer VS, Perez GR. Psychiatric co-morbidity is associated with increased risk of surgery in crohn’s disease. Aliment Pharmacol Ther. 2013;37(4):445–454.
   PubMed Web of Science ®Google Scholar
• Royal College of Psychiatrists PS04/19. Position statement on antidepressants and depression; 2019. https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/position-statements/ps04_19—antidepressants-and-depression.pdf?sfvrsn=ddea9473_5].
   Google Scholar
• NICE national institute for health and clinical excellence generalised anxiety disorder and panic disorder in adults: management NICE clin guidel 113 guid; 2011. https://www.nice.org.uk/guidance/cg113.
   Google Scholar
• Mikocka-Walus A, Prady SL, Pollok J, et al. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev. 2019;4:CD012680.
   PubMedGoogle Scholar
• Frolkis AD, Vallerand IA, Shaheen AA, et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut. 2019 Sep;68(9):1606–1612.
   PubMed Web of Science ®Google Scholar
• Macer BJ, Prady S, Mikocka-Walus A. Antidepressants in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2017;23(4):534–550.
   PubMed Web of Science ®Google Scholar
• Goodhand JR, Greig FL, Koodun Y, et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis. 2012;18(7):1232–1239. DOI:10.1002/ibd.21846
   PubMed Web of Science ®Google Scholar
• Daghaghzadeh H, Naji F, Afshar H, et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double-blind controlled study. J Res Med Sci. 2015 Jun;20(6):595–601.
   PubMed Web of Science ®Google Scholar